DCM
Driehaus Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-503,039
| Closed | -$29.6M | – | 365 |
|
|
2024
Q1 | $29.6M | Buy |
503,039
+21,538
| +4% | +$1.27M | 0.29% | 104 |
|
|
2023
Q4 | $28.8M | Buy |
481,501
+300,177
| +166% | +$18M | 0.35% | 89 |
|
|
2023
Q3 | $6.9M | Sell |
181,324
-166,052
| -48% | -$6.32M | 0.09% | 257 |
|
|
2023
Q2 | $31.6M | Buy |
347,376
+76,683
| +28% | +$6.99M | 0.4% | 83 |
|
|
2023
Q1 | $17.9M | Sell |
270,693
-22,852
| -8% | -$1.51M | 0.25% | 135 |
|
|
2022
Q4 | $15.2M | Sell |
293,545
-564,586
| -66% | -$29.2M | 0.23% | 152 |
|
|
2022
Q3 | $58.6M | Buy |
858,131
+97,982
| +13% | +$6.69M | 0.89% | 21 |
|
|
2022
Q2 | $34.4M | Buy |
760,149
+131,504
| +21% | +$5.95M | 0.56% | 42 |
|
|
2022
Q1 | $31.9M | Buy |
628,645
+365,748
| +139% | +$18.6M | 0.39% | 83 |
|
|
2021
Q4 | $12.4M | Sell |
262,897
-12,655
| -5% | -$598K | 0.13% | 217 |
|
|
2021
Q3 | $9.08M | Buy |
275,552
+16,159
| +6% | +$533K | 0.11% | 248 |
|
|
2021
Q2 | $16.4M | Sell |
259,393
-4,248
| -2% | -$268K | 0.22% | 149 |
|
|
2021
Q1 | $11.3M | Sell |
263,641
-126,310
| -32% | -$5.42M | 0.17% | 189 |
|
|
2020
Q4 | $22.3M | Buy |
389,951
+1,914
| +0.5% | +$109K | 0.36% | 88 |
|
|
2020
Q3 | $11.7M | Sell |
388,037
-37,754
| -9% | -$1.14M | 0.24% | 116 |
|
|
2020
Q2 | $13.9M | Sell |
425,791
-86,679
| -17% | -$2.83M | 0.34% | 102 |
|
|
2020
Q1 | $13.7M | Buy |
512,470
+55,806
| +12% | +$1.5M | 0.46% | 62 |
|
|
2019
Q4 | $14M | Buy |
456,664
+316,320
| +225% | +$9.69M | 0.37% | 73 |
|
|
2019
Q3 | $3.38M | Buy |
+140,344
| New | +$3.38M | 0.11% | 199 |
|